-
Whole-genome sequencing of bladder cancers of various stages and grades to search for driver mutations, chromosome-scale somatic changes, mutation signatures and clonal structures.
Study
EGAS00001000738
-
Multiregional sequencing of IDH-WT glioblastoma reveals high genetic heterogeneity and a dynamic evolutionary history
Study
EGAS00001005128
-
Whole Genome Sequencing of Liver Cancers
Study
EGAS00001002408
-
Adeno-associated virus in the liver: natural history and consequences in tumor development
Study
EGAS00001003310
-
RNA-seq of Glioblastoma stem cells
Study
EGAS00001003070
-
UCSF Pediatric Bithalamic Glioma Genome Project
Study
EGAS00001004033
-
Most HCCs in Taiwan show the mutational signature of aristolochic acid
Study
EGAS00001002301
-
Multi-omics analysis of serial samples from metastatic TNBC patients on PARP inhibitor monotherapy provide insight into rational PARP inhibitor therapy combinations
Study
EGAS00001005479
-
High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma
Study
EGAS00001003493
-
Microbiota 16S sequencing study in NSCLC patients eligible for surgery without neoadjuvant treatment
Study
EGAS00001004728
-
Single-cell multi-omics of relapse/refractory multiple myeloma patients (Hipo K08K/H067/K43R)
Study
EGAS00001006538
-
Persistent Mutation Burden Drives Sustained Anti-Tumor Immune Responses
Study
EGAS00001006660
-
A Genome-Wide Association Study in Patients Experiencing Musculoskeletal Adverse Events on NCIC CTG Trial MA.27 Evaluating Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer. A Collaboration Between the NIH Pharmacogenetics Research Network and the RIKEN Yokohama Institute Center for Genomic Medicine.
Study
phs000210
-
_WGS__Somatic_mutation_in_skin_epidermis__SMS_
Study
EGAS00001004464
-
Chondrosarcoma_Targeted_Sequencing_Study
Study
EGAS00001000277
-
CHEK2 molecular manuscript
Study
EGAS50000000080
-
Anti-tumor and Immune Stimulatory Activity of Iberdomide in Myeloma, Including Patients with Cereblon Dysregulation
Study
EGAS50000000265
-
Lung cancer Early Molecular Assessment
Study
EGAS50000000896
-
Development of actionable molecular targets and/or biomarkers for prognostication and patient stratification in gynecological cancer based on whole-exome sequencing and epigenomic analysis
Study
JGAS000642
-
Molecular classification of small intestinal adenocarcinomas
Study
EGAS50000001238
-
Targeted_Sequencing_of_Human_Myeloid_Malignancies
Study
EGAS00001001289
-
Lymphocyte_LCM_WGS
Study
EGAS00001003384
-
Comparison of fresh and slow-frozen cancer samples for different applications
Study
EGAS00001005891
-
Somatic_mutation_and_clonal_evolution_in_the_human_pancreas___WGS
Study
EGAS00001002626
-
Personalised Mapping of Tumour Development in Synchronous Colorectal Cancer Patients
Study
EGAS00001004413